Nanomedicine for Glioblastoma Therapy: Novel Insights and Future Perspectives

纳米医学 胶质母细胞瘤 医学 药物输送 限制 靶向给药 纳米技术 纳米载体 药品 转化研究 血脑屏障 临床试验 转化医学 纳米技术的应用 脑瘤 药物发现 生物相容性材料 计算机科学
作者
Yu Guo,Keqiang Lu,Wenmiao Luo,Min Wei,Fangbao Li,Maoxiang Li,Juanjuan Peng,Mingfei Yang,Lingzhi Zhao,Hengzhu Zhang
出处
期刊:Wiley Interdisciplinary Reviews-nanomedicine and Nanobiotechnology [Wiley]
卷期号:18 (4): e70071-e70071 被引量:4
标识
DOI:10.1002/wnan.70071
摘要

Glioblastoma (GBM) remains one of the most aggressive primary brain tumors, with poor prognosis, high recurrence, and limited therapeutic options. Although substantial progress has been made in drug development, effective clinical translation is still constrained by inefficient delivery across the blood brain barrier (BBB) and blood brain tumor barrier (BBTB), insufficient tumor accumulation, intratumoral heterogeneity, acquired therapeutic resistance, and dose limiting systemic toxicity. Nanomedicine offers a promising strategy to address these barriers through tunable physicochemical properties, flexible surface functionalization, improved pharmacokinetics, and controllable drug release. In this review, we systematically summarize recent advances in nanomedicine enabled GBM therapy from four interrelated perspectives: the optimization of nanomaterial properties, the development of goal-oriented targeting strategies, the rationalization of delivery routes, and the engineering of smart stimuli-responsive nano-systems. Rather than only cataloguing representative nanoplatforms, we emphasize how material parameters, biological targeting mechanisms, delivery routes, and release behaviors are mechanistically linked to BBB or BBTB penetration, tumor accumulation, therapeutic efficacy, and translational feasibility. Importantly, we also incorporate a key failure case analysis of representative clinical and preclinical studies, highlighting why promising nanotherapeutic concepts may fail because of inadequate intratumoral distribution, insufficient survival benefit, poor patient selection, manufacturing complexity, safety concerns, or impractical trial design. By integrating delivery mechanisms, cross platform comparison, translational barriers, and future optimization principles, this review provides a critical and forward looking framework for the rational design of precise, effective, and clinically translatable nanomedicine strategies for GBM treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim的应助被科研通管家采纳,获得30
刚刚
FashionBoy的应助被科研通管家采纳,获得10
1秒前
董晴发布了新的文献求助10
1秒前
秋风的应助被科研通管家采纳,获得10
1秒前
1秒前
无花果的应助被科研通管家采纳,获得10
1秒前
情怀的应助被科研通管家采纳,获得10
1秒前
领导范儿的应助被科研通管家采纳,获得10
1秒前
共享精神的应助被科研通管家采纳,获得10
1秒前
大模型的应助被科研通管家采纳,获得10
1秒前
SciGPT的应助被科研通管家采纳,获得10
2秒前
隐形曼青的应助被科研通管家采纳,获得10
2秒前
11发布了新的文献求助10
2秒前
无花果的应助被科研通管家采纳,获得10
2秒前
大气大侠发布了新的文献求助10
2秒前
2秒前
2秒前
molihuakai的应助被科研通管家采纳,获得10
2秒前
CipherSage的应助被迷人的柚子采纳,获得10
2秒前
今后的应助被科研通管家采纳,获得10
2秒前
2秒前
3秒前
92567发布了新的文献求助10
3秒前
于呆呆发布了新的文献求助30
3秒前
3秒前
上官若男的应助被LiuZhe采纳,获得10
3秒前
4秒前
moon完成签到,获得积分10
4秒前
岩追研发布了新的文献求助10
4秒前
qin202569发布了新的文献求助10
5秒前
CodeCraft的应助被Rony采纳,获得10
5秒前
东山完成签到,获得积分10
6秒前
一步一步完成签到,获得积分10
6秒前
晚晚发布了新的文献求助10
6秒前
6秒前
英俊的铭的应助被Lily采纳,获得10
6秒前
ccone完成签到,获得积分10
7秒前
ssiyyu发布了新的文献求助10
7秒前
7秒前
端庄威发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124